Targeted Strategies for Today's Evolving Markets

MissionIR Blog

NeoGenomics, Inc. (NGNM) to Present at the 13th Annual B. Riley & Co. Investor Conference

NeoGenomics (OTCQB: NGNM), a high-complexity, CLIA-certified clinical laboratory, specializes in the fastest-growing segment of the laboratory industry: cancer genetics diagnostic testing. Included in the company’s testing services are cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetic testing. The company services the needs of pathologists, oncologists and other clinicians, as well as hospitals, throughout the U.S. For more information, visit the company’s Web site at www.neogenomics.com

B. Riley & Co. provides a full array of corporate finance, research, sales, trading, and otcqx dad services to corporate, institutional, and high net worth clients.  Headquartered in Los Angeles, with offices in San Francisco, New York, and Newport Beach, the firm is recognized for its distinguished equity research, merger and acquisitions advisory services, initial and secondary public offerings, and institutional private placements. For more information on B. Riley & Co., visit www.brileyco.com

Let us hear your thoughts below:

This year's annual B. Riley & Co. Conference will take place on May 20-22, 2013. Bringing together executives from more than 200 companies, the 14th Annual B. Riley & Co. Conference will represent a broad range of consumer and technology sub-sectors. For more information on B. Riley & Co., visit www.brileyco.com.
This entry was posted in B. Riley & Co. Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *